StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note published on Tuesday morning. The firm issued a hold rating on the stock.
China Pharma Price Performance
Shares of CPHI stock opened at $0.26 on Tuesday. The company has a quick ratio of 0.24, a current ratio of 0.84 and a debt-to-equity ratio of 0.19. China Pharma has a 12 month low of $0.17 and a 12 month high of $1.16. The company has a 50 day simple moving average of $0.23 and a two-hundred day simple moving average of $0.25.
China Pharma (NYSE:CPHI – Get Free Report) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) EPS for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%. The company had revenue of $0.93 million during the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Read More
- Five stocks we like better than China Pharma
- 3 Healthcare Dividend Stocks to Buy
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
